GJC3

gene
On this page

Also known as CX30.2CX29

Summary

GJC3 (gap junction protein gamma 3, HGNC:17495) is a protein-coding gene on chromosome 7q22.1, encoding Gap junction gamma-3 protein (Q8NFK1). One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.

This gene encodes a gap junction protein. The encoded protein, also known as a connexin, plays a role in formation of gap junctions, which provide direct connections between neighboring cells. Mutations in this gene have been reported to be associated with nonsyndromic hearing loss.

Source: NCBI Gene 349149 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 41 total
  • MANE Select transcript: NM_181538

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17495
Approved symbolGJC3
Namegap junction protein gamma 3
Location7q22.1
Locus typegene with protein product
StatusApproved
AliasesCX30.2, CX29
Ensembl geneENSG00000176402
Ensembl biotypeprotein_coding
OMIM611925
Entrez349149

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000312891

RefSeq mRNA: 1 — MANE Select: NM_181538 NM_181538

CCDS: CCDS34697

Canonical transcript exons

ENST00000312891 — 2 exons

ExonStartEnd
ENSE000012315049992326699923603
ENSE000012315139992884099929620

Expression profiles

Bgee: expression breadth ubiquitous, 120 present calls, max score 84.70.

Top tissues by expression

128 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
tibial nerveUBERON:000132384.70gold quality
body of pancreasUBERON:000115080.55gold quality
olfactory segment of nasal mucosaUBERON:000538678.85gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.52gold quality
minor salivary glandUBERON:000183076.25gold quality
saliva-secreting glandUBERON:000104475.78gold quality
sural nerveUBERON:001548874.32gold quality
thoracic mammary glandUBERON:000520073.16gold quality
pancreasUBERON:000126470.96gold quality
prostate glandUBERON:000236770.62gold quality
skin of legUBERON:000151167.94gold quality
zone of skinUBERON:000001466.05gold quality
liverUBERON:000210764.67gold quality
right lobe of liverUBERON:000111464.63gold quality
placentaUBERON:000198764.34gold quality
skin of abdomenUBERON:000141663.83gold quality
subcutaneous adipose tissueUBERON:000219062.50gold quality
body of stomachUBERON:000116162.04gold quality
adipose tissueUBERON:000101360.40gold quality
fundus of stomachUBERON:000116059.49gold quality
substantia nigraUBERON:000203859.24gold quality
stomachUBERON:000094558.87gold quality
tonsilUBERON:000237258.42gold quality
right lungUBERON:000216757.96gold quality
omental fat padUBERON:001041457.74gold quality
testisUBERON:000047355.84gold quality
left testisUBERON:000453355.78gold quality
left coronary arteryUBERON:000162655.45gold quality
putamenUBERON:000187455.45gold quality
right testisUBERON:000453455.35gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-CURD-114yes8.03
E-ANND-3yes4.57

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): TBX3

miRNA regulators (miRDB)

24 targeting GJC3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-12118100.0065.881270
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-311999.9271.342390
HSA-MIR-221-3P99.8671.561329
HSA-MIR-222-3P99.8671.351337
HSA-MIR-431999.7669.832586
HSA-MIR-6764-5P99.7567.892304
HSA-MIR-129099.5969.902079
HSA-MIR-1915-3P99.5866.791988
HSA-MIR-29799.4069.581418
HSA-MIR-125A-5P99.3670.591640
HSA-MIR-125B-5P99.3670.361662
HSA-MIR-4717-3P99.0666.341072
HSA-MIR-392698.9569.261438
HSA-MIR-942-3P98.8169.04876
HSA-MIR-314998.7767.131639
HSA-MIR-4520-3P98.7566.55963
HSA-MIR-390898.7567.311160
HSA-MIR-445098.2668.35725
HSA-MIR-7154-3P97.6565.02985
HSA-MIR-616-3P96.8266.99784
HSA-MIR-675-3P95.7769.27675

Literature-anchored findings (GeneRIF, showing 9)

  • Cx31.3 is localized to the gray matter along small myelinated fibers and is co-expressed with Cx32 in oligodendrocytes. (PMID:18353664)
  • We suggest that the c.[43C–>G(+)230G–>C] compound heterozygous variant of Cx29 may be a risk factor for the development of hearing loss in Taiwanese. (PMID:19657183)
  • Data show that the p.E269D missense mutation resulted in accumulation of the Cx29 mutant protein in the endoplasmic reticulum rather than in the cytoplasmic membrane. (PMID:19876648)
  • Mutations in the Cx29 gene do not play a role in the causation of non syndromic hearing impairment in Indian population. (PMID:20632892)
  • The connexin30.2/CX31.3 shares functional properties with pannexin (hemi) channels rather than gap junction channels of other Connexins. (PMID:21480002)
  • Although p.R15G and p.L23H mutants do not decrease the trafficking of CX proteins, mutations in GJC3 genes result in a loss of hemichannel function of CX30.2/CX31.3 protein, possibly causing hearing loss. (PMID:23179405)
  • Based on these findings, we suggest that p.W77S mutant has a dominant negative effect on the formation and function of the gap junction. These results give a novel molecular elucidation for the mutation of GJC3 in the development of hearing loss. (PMID:28367085)
  • GJB4 and GJC3 variants in non-syndromic hearing impairment in Ghana. (PMID:32524838)
  • Pelizaeus-Merzbacher-Like Disease 1 Caused by a Novel Mutation in GJC2 Gene: A Case Report. (PMID:34840390)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusGjc3ENSMUSG00000056966
rattus_norvegicusGjc3ENSRNOG00000001329

Paralogs (20): GJA8 (ENSG00000121634), GJB6 (ENSG00000121742), GJA3 (ENSG00000121743), GJA9 (ENSG00000131233), GJA10 (ENSG00000135355), GJA1 (ENSG00000152661), GJD2 (ENSG00000159248), GJB7 (ENSG00000164411), GJB2 (ENSG00000165474), GJB1 (ENSG00000169562), GJD4 (ENSG00000177291), GJC1 (ENSG00000182963), GJD3 (ENSG00000183153), GJA4 (ENSG00000187513), GJB3 (ENSG00000188910), GJB5 (ENSG00000189280), GJB4 (ENSG00000189433), GJC2 (ENSG00000198835), GJE1 (ENSG00000203733), GJA5 (ENSG00000265107)

Protein

Protein identifiers

Gap junction gamma-3 proteinQ8NFK1 (reviewed: Q8NFK1)

Alternative names: Connexin-30.2, Connexin-31.3, Gap junction epsilon-1 protein

All UniProt accessions (1): Q8NFK1

UniProt curated annotations — full annotation on UniProt →

Function. One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.

Subunit / interactions. A connexon is composed of a hexamer of connexins.

Subcellular location. Cell membrane. Cell junction. Gap junction.

Tissue specificity. CNS specific. Expression is restricted to brain, spinal cord, and sciatic nerve. According to PubMed:12881038, expression is abundant in skeletal muscle, liver, and heart, and to a minor degree in pancreas and kidney.

Similarity. Belongs to the connexin family. Gamma-type subfamily.

RefSeq proteins (1): NP_853516* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000500ConnexinFamily
IPR013092Connexin_NDomain
IPR017990Connexin_CSConserved_site
IPR019570Connexin_CCCDomain
IPR038359Connexin_N_sfHomologous_superfamily

Pfam: PF00029

UniProt features (27 total): helix 9, topological domain 5, transmembrane region 4, turn 3, strand 3, chain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

3 structures.

PDBMethodResolution (Å)
6L3TELECTRON MICROSCOPY2.34
6L3UELECTRON MICROSCOPY2.53
6L3VELECTRON MICROSCOPY2.63

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NFK1-F175.710.43

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 77 (showing top): GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS, GOBP_GROWTH, GOBP_CELL_CELL_SIGNALING, GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION, GOBP_ENSHEATHMENT_OF_NEURONS, GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING, GOBP_ORGAN_GROWTH, GOBP_REGULATION_OF_SYSTEM_PROCESS, GOBP_SENSORY_PERCEPTION, GOBP_HEART_PROCESS, GOBP_SENSORY_ORGAN_DEVELOPMENT, GOCC_CELL_CELL_JUNCTION, GOBP_CARDIAC_CONDUCTION, GOBP_TRANSMEMBRANE_TRANSPORT

GO Biological Process (5): cell-cell signaling (GO:0007267), sensory perception of sound (GO:0007605), myelination (GO:0042552), cell communication (GO:0007154), transmembrane transport (GO:0055085)

GO Molecular Function (3): gap junction channel activity (GO:0005243), identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (6): connexin complex (GO:0005922), myelin sheath (GO:0043209), plasma membrane (GO:0005886), gap junction (GO:0005921), membrane (GO:0016020), anchoring junction (GO:0070161)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular process2
cellular anatomical structure2
cell communication1
signaling1
sensory perception of mechanical stimulus1
axon ensheathment1
transport1
wide pore channel activity1
protein binding1
binding1
gap junction1
plasma membrane protein complex1
membrane1
cell periphery1
cell-cell junction1
cell junction1

Protein interactions and networks

STRING

346 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GJC3KCNA2P16389827
GJC3AP1S1P61966788
GJC3GJA5P36382487
GJC3GJC1P36383470
GJC3PBXIP1Q96AQ6430
GJC3PANX1Q96RD7428
GJC3PANX2Q96RD6385
GJC3ZMAT2Q96NC0382
GJC3PMVKQ15126379
GJC3PANX3Q96QZ0370
GJC3ERMNQ8TAM6364
GJC3LGI4Q8N135360
GJC3OR10H3O60404356
GJC3KCNA1Q09470348
GJC3AZGP1P25311347

IntAct

7 interactions, top by confidence:

ABTypeScore
MS4A13GJC3psi-mi:“MI:0915”(physical association)0.560
STX7GJC3psi-mi:“MI:0915”(physical association)0.560
MS4A13GJC3psi-mi:“MI:0915”(physical association)0.000
STX7GJC3psi-mi:“MI:0915”(physical association)0.000

BioGRID (2): GJC3 (Two-hybrid), MS4A13 (Two-hybrid)

ESM2 similar proteins: A3KN25, A4IFL1, O18968, O70491, O75712, O95377, P08033, P25305, P28230, P28231, P28232, P28233, P28234, P28235, P29414, P33725, P35212, P36380, P36382, P41987, Q01231, Q02738, Q02739, Q03190, Q08DF2, Q0V8E7, Q0VCR2, Q29RK8, Q4QR83, Q58D78, Q5E9Z5, Q5R7B4, Q60HF7, Q64448, Q6WGK6, Q7M734, Q80VM9, Q866T7, Q8BSD4, Q8CE93

Diamond homologs: A2VE67, A3KN25, A4GG66, A4GVD1, A4IFL1, A6XKM2, O18968, O57474, O93533, O95377, O95452, P08033, P08034, P08050, P08983, P14154, P16863, P16864, P17302, P18246, P18860, P18861, P21994, P23242, P25305, P28228, P28229, P28230, P28231, P28232, P28233, P28234, P28235, P28236, P29033, P29414, P29415, P33725, P35212, P36381

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

41 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance30
Likely benign7
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

644 predictions. Top by Δscore:

VariantEffectΔscore
6:142133846:ACAGG:Aacceptor_loss1.0000
6:142133847:CAGG:Cacceptor_loss1.0000
6:142133849:G:GAacceptor_loss1.0000
6:142133193:GATGT:Gdonor_gain0.9900
6:142133194:ATGT:Adonor_gain0.9900
6:142133194:ATGTG:Adonor_loss0.9900
6:142133195:TGT:Tdonor_gain0.9900
6:142133195:TGTGT:Tdonor_loss0.9900
6:142133196:GT:Gdonor_gain0.9900
6:142133196:GTG:Gdonor_gain0.9900
6:142133196:GTGTA:Gdonor_loss0.9900
6:142133197:TGT:Tdonor_gain0.9900
6:142133198:G:GAdonor_loss0.9900
6:142133198:G:GGdonor_gain0.9900
6:142133199:TA:Tdonor_loss0.9900
6:142133200:AA:Adonor_loss0.9900
6:142133837:A:AGacceptor_gain0.9900
6:142133838:A:Gacceptor_gain0.9900
6:142133840:A:Gacceptor_gain0.9900
6:142133843:A:AGacceptor_gain0.9900
6:142133844:T:Gacceptor_gain0.9900
6:142133849:GGTT:Gacceptor_gain0.9900
6:142133849:GGTTA:Gacceptor_gain0.9900
7:99923605:T:Cacceptor_gain0.9900
7:99923608:T:TCacceptor_gain0.9900
7:99928439:A:ACdonor_gain0.9900
7:99928440:C:CCdonor_gain0.9900
6:142133193:G:GTdonor_gain0.9800
6:142133198:GTA:Gdonor_gain0.9800
6:142133201:AG:Adonor_loss0.9800

AlphaMissense

1787 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:99929469:A:CF51C0.958
7:99929468:G:CF51L0.952
7:99929468:G:TF51L0.952
7:99929470:A:GF51L0.952
7:99929024:G:CS199R0.910
7:99929024:G:TS199R0.910
7:99929026:T:GS199R0.910
7:99929357:G:CS88R0.910
7:99929357:G:TS88R0.910
7:99929359:T:GS88R0.910
7:99929429:G:CC64W0.895
7:99929082:C:GC180S0.885
7:99929083:A:TC180S0.885
7:99929393:G:CF76L0.883
7:99929393:G:TF76L0.883
7:99929395:A:GF76L0.883
7:99929463:C:GC53S0.882
7:99929464:A:TC53S0.882
7:99929442:C:GC60S0.879
7:99929443:A:TC60S0.879
7:99929533:C:GG30R0.873
7:99929533:C:TG30R0.873
7:99929430:C:TC64Y0.865
7:99929361:G:CP87R0.862
7:99929178:T:AE148V0.861
7:99929426:G:CF65L0.854
7:99929426:G:TF65L0.854
7:99929428:A:GF65L0.854
7:99929361:G:TP87H0.853
7:99929033:A:CF196L0.849

dbSNP variants (sampled 300 via entrez): RS1000151093 (7:99925355 G>T), RS1000336889 (7:99931221 G>A), RS1001102546 (7:99926731 A>G), RS1001156367 (7:99926909 A>G), RS1002101702 (7:99927815 G>T), RS1003148176 (7:99926471 A>G), RS1003464720 (7:99922962 G>A), RS1003859634 (7:99930551 T>C), RS1004062579 (7:99924461 G>A,C), RS1004299440 (7:99928003 G>A), RS1004636100 (7:99926893 G>A), RS1004862021 (7:99932182 G>A), RS1005123758 (7:99932453 T>C,G), RS1005475940 (7:99926205 G>A,C), RS1005617875 (7:99927498 C>T)

Disease associations

OMIM: gene MIM:611925 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST010002_259Refractive error3.000000e-16

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: other ic — Connexins and Pannexins

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
2-amino-3,8-dimethylimidazo(4,5-f)quinoxalineincreases expression1
Grape Seed Proanthocyanidinsaffects cotreatment, increases expression1
Benzo(a)pyreneincreases methylation1
Catechinincreases expression, affects cotreatment1
Rotenonedecreases expression1
Silicon Dioxideincreases expression1
Aflatoxin B1increases methylation1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.